Effect of AC2993 With or Without Immunosuppression on Beta Cell Function in Patients With Type I Diabetes

Clinical trial NCT00064714 · COMPLETED

Trial details

NCT number: NCT00064714
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Diabetes Mellitus

Start date: 2003-07-01
Primary completion: 2008-03-01
Enrollment: 47

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.